Measuring and Statistically Testing the Size of the Effect of a Chemical Compound on a Continuous In-Vitro Pharmacological Response Through a New Statistical Model of Response Detection Limit.
Diaz, Francisco J; McDonald, Peter R; Pinter, Abraham; Chaguturu, Rathnam.
J Biopharm Stat
; 25(4): 757-80, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-24905187
Association between antiretroviral therapy adherence and employment status: systematic review and meta-analysis.
Prevention of mother-to-child transmission of HIV: assessing the accuracy of routinely collected data on maternal antiretroviral prophylaxis coverage in Kenya.
A simple and flexible graphical approach for adaptive group-sequential clinical trials.
Temporal trends in the discontinuation of first-line antiretroviral therapy.
Maximum type I error rate inflation from sample size reassessment when investigators are blind to treatment labels.
Statistical controversies in clinical research: building the bridge to phase II-efficacy estimation in dose-expansion cohorts.
Modeling clinical endpoints as a function of time of switch to second-line ART with incomplete data on switching times.
A Bayesian approach to improved estimation of causal effect predictiveness for a principal surrogate endpoint.
Adaptive graph-based multiple testing procedures.
Novel Approaches for Visualizing and Analyzing Dose-Timing Data from Electronic Drug Monitors, or "How the 'Broken Window' Theory Pertains to ART Adherence".